beta-thujaplicin has been researched along with Benign Neoplasms in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Additionally, β-thujaplicin sensitizes cancer cells to PARP inhibitor in different cancer cell lines." | 1.46 | Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy. ( Brown, PH; Peng, G; Peng, X; Peng, Y; Shen, J; Tu, W; Uray, IP; Wang, L; Zhang, L, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Peng, Y | 1 |
| Uray, IP | 1 |
| Shen, J | 1 |
| Wang, L | 1 |
| Peng, X | 1 |
| Brown, PH | 1 |
| Tu, W | 1 |
| Peng, G | 1 |
1 other study available for beta-thujaplicin and Benign Neoplasms
| Article | Year |
|---|---|
Natural product β-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cupressaceae; DNA; DNA Breaks, Double-Stranded; Drug Therap | 2017 |